San Francisco, California Patent of the Year – 2024/2025

Reveal Biosensors Inc. has been awarded the 2024/2025 Patent of the Year for its groundbreaking innovation in wearable health monitoring. Their invention, detailed in U.S. Patent No. 12156723, titled ‘Energy conversion monitoring devices and methods’, introduces an Energy Conversion Monitor (ECM) sensor that measures tissue-level oxygen metabolism more sensitively than traditional pulse oximeters.

Unlike conventional devices that assess blood oxygen saturation, the ECM sensor evaluates how effectively the body converts oxygen into energy at the tissue level. This provides a more accurate picture of physiological stress, particularly in conditions like sleep-disordered breathing (SDB). Worn as an upper-arm band, the ECM can detect hypoxic stress earlier and more reliably than existing methods.

The technology has broad applications. It can be integrated into sleep lab equipment, used for home diagnostics, and assist in managing airway therapy devices. Additionally, it offers continuous monitoring for sleep quality in the general population. Beyond sleep health, the ECM aids in assessing physiological stress during and after exercise, guiding oxygen therapy in premature infants, and monitoring resuscitation efforts in hypoxic conditions. It also holds promise for early detection of sepsis in vulnerable populations.

Reveal Biosensors Inc.’s ECM sensor represents a significant advancement in wearable health technology, offering a more nuanced understanding of the body’s oxygen utilization. This innovation has the potential to transform how we monitor and respond to various health conditions, from sleep disorders to critical care scenarios.